INTRODUCTION: @entity263 is common and the incidence is increasing, but more @entity1 are living longer after diagnosis, and die with their disease rather than of it. Nonetheless, specific and substantial physical, @entity458 often lead to a poor quality of life. Urology services increasingly struggle to cope with the demands of follow-up care, and primary care is likely to play the central role in long-term follow-up. The present phase II trial will evaluate the feasibility and acceptability of a nurse-led, @entity1 -centred psychoeducational intervention, delivered in community or primary care settings. METHODS AND ANALYSIS: @entity263 survivors diagnosed in the past 9-48   months and currently biochemically stable will be identified from hospital records by their treating clinician. Eligible @entity1 would have either completed radical treatment, or would be followed up with @entity1486 monitoring and symptom reporting. We will recruit 120 @entity1 who will be randomised to receive either an augmented form of usual care, or an additional nurse-led intervention for a period of 36   weeks. Following the health policy in Wales, the intervention is offered by a key worker, is promoting prudent healthcare and is using a holistic needs assessment. Outcome measures will assess physical symptoms, psychological well-being, confidence in managing own health and quality of life. Healthcare service use will be measured over 36   weeks. Feedback interviews with @entity1 and clinicians will further inform the acceptability of the intervention. Recruitment, @entity6661 , questionnaire completion rates and outcome measures variability will be assessed, and results will inform the design of a future phase III trial and accompanying economic evaluation. ETHICS AND DISSEMINATION: Ethics approval was granted by Bangor University and North Wales REC (13/WA/0291). Results will be reported in peer-reviewed publications, at scientific conferences, and directly through national @entity5 and primary care networks. TRIAL REGISTRATION NUMBER: ISRCTN 34516019.

A pilot randomised controlled @entity263 ( XXXX ): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocol.

@entity1 :: ('9606', 'Species') :: ['patients', 'person', 'men'] @entity263 :: ('MESH:D011471', 'Disease') :: ['Prostate cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer'] @entity458 :: ('MESH:D020018', 'Disease') :: ['sexual, emotional and mental health problems'] @entity6661 :: ('MESH:D019217', 'Disease') :: ['attrition'] @entity1486 :: ('354', 'Gene') :: ['prostate specific antigen']
@entity263 :: (MESH:D011471,Disease) :: ['TOPCAT-P']
